Skip to main content
Funded Studies

Jean-Cosme Dodart

SVP, Preclinical R&D at Vaxxinity

Location: Boston, MA United States

Jean-Cosme Dodart is senior vice president of preclinical R&D at Vaxxinity. Dr. Dodart brings to Vaxxinity over 20 years of experience in neuroscience drug development at both large pharmaceutical companies (Lilly, Merck, Novartis) and small biotech companies (Sage Therapeutics, Wave Life Sciences). He has a strong track record ofsuccess in drug discovery and has worked in many disorders affecting the nervous system, including Alzheimer’s disease, Parkinson’s disease, neuromuscular disorders, pain and depression. Many of the pre-clinical projects that Dr. Dodart has persued have made it into clinical testing including several promising drug candidates that are currently in clinical trials. Dr. Dodart earned his MS degree in cell biology and physiology from the University Pierre and Marie Curie in Paris and his PhD in neuroscience from the University Louis Pasteur in Strasbourg, France.

Associated Grants

  • Development of a Method for Assessing the Effectiveness of Alpha-synuclein Immunotherapy


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.